Humana Inc.’s Stock Price Drops to $315.98, Experiencing a 3.66% Decline: A Deep Dive into HUM’s Performance

Humana Inc. (HUM)

315.98 USD -12.00 (-3.66%) Volume: 3.49M

Humana Inc.’s stock price is currently valued at 315.98 USD, experiencing a decrease of -3.66% this trading session with a trading volume of 3.49M. The company’s shares have seen a year-to-date (YTD) decline of -30.98%, reflecting significant volatility in the market.

Latest developments on Humana Inc.

Humana Inc. has reported mixed Q1 2024 results, with a significant beat on profits driven by the strength of its Medicare business, leading to a surge in the company’s stock despite overall market underperformance. However, the insurer has withdrawn its 2025 profit forecast due to disappointing Medicare rates, leading to murkier outlook for the Medicare Advantage program. Despite this, Humana has raised its outlook for Medicare Advantage membership growth following its successful Q1 performance. The company also expanded its prior authorization partnership with Cohere Health, adding diagnostic imaging and sleep services.

Humana Inc. on Smartkarma

According to a recent report by Baptista Research on Smartkarma, Humana Inc has exceeded revenue and earnings expectations set by Wall Street. The company’s adjusted earnings per share reached $7.78, with strong performance in Medicaid and primary care. Looking towards 2024, Humana is focusing on its strategic approach to Medicare Advantage, prioritizing consumer preferences and maintaining key benefits.

The analysis by Baptista Research, available on Smartkarma, highlights Humana Inc‘s launch of an At-Home Primary Care Program and other developments. The report leans bullish on the company’s prospects, noting the successful surpassing of revenue and earnings expectations. With a focus on consumer preferences and key benefits, Humana is positioning itself for growth in the Medicare Advantage market.

A look at Humana Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Humana Inc. has a positive long-term outlook. With a high Value score of 4, the company is seen as having strong potential for growth and profitability. This indicates that Humana Inc. is undervalued compared to its peers, making it an attractive investment option for investors looking for value.

Additionally, Humana Inc. scores well in Dividend, Growth, Resilience, and Momentum, with scores of 3 across the board. This suggests that the company is likely to continue paying dividends, experiencing steady growth, remaining resilient in the face of challenges, and maintaining positive momentum in the market. Overall, Humana Inc. is well-positioned for success in the managed health care industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma